|
(b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.Procode is krd/hcg.The name, phone and email address of the initial reporter are not available / reported.[conclusion]: the healthcare professional reported that during an aneurysm coil embolization procedure, it was reported that the 3mm x 6cm micrusframe 14 coil (mfr140306 / l17147) failed to be re-sheathed.No further information related to the procedure or to the device issue is available.There was no report of any patient consequence.The complaint device was returned for evaluation and analysis.The investigational finding is documented below.Investigation summary: the non-sterile 3mm x 6cm micrusframe 14 coil was received.Visual inspection was performed.It was observed that the introducer is split at the area covering the device positioning unit (dpu), this caused the dpu to protrude from the introducer through the area of the split.Procedural and other factors may have contributed to the observed split introducer; however, this cannot conclusively be determined.The dpu protruding from the introducer is related to the reported issue that the coil failed to be re-sheathed; this observation confirmed the reported issue.No other damages nor anomalies were observed during the visual inspection.The returned complaint device underwent a microscopic inspection.Under magnification, it was noted that the embolic coil component is in stretched condition.Functional evaluation was precluded due to the stretched condition of the embolic coil.A review of manufacturing documentation associated with this lot (l17147) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no nonconformances related to device manufacture or inspection.All product rejected during manufacturing was identified as scrap and properly accounted for.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.It should be noted that product failure could be caused by multiple factors.The instructions for use (ifu) does contain the following recommendation: do not fasten the rhv valve too tightly around the introducer sheath since excessive pressure may cause damage to the introducer sheath and/or the microcoil as it is advanced into the infusion microcatheter.Additionally, if the introducer tip and microcatheter hub are misaligned, damage may occur to the microcoil as it passes through this transition.Coil stretching is known potential issue associated with the use of this device.The ifu provides proper handling instructions for the device to prevent such issue as stretching from occurring.The coil stretched condition was not originally reported in the complaint.Stretching can occur during procedure handling where force may have been inadvertently applied.The exact cause of the observed stretched condition could not be conclusively determined; however, it is possible that during the failed attempt to resheath the coil, some force was inadvertently exerted on the coil resulting in the observed stretched condition, causing the introducer sheath to split as noted during the visual inspection and the dpu to protrude through the split area.It was reported that no further information related to the procedure and the reported device issue is available.Based on the device history record review, there is no indication that the event is related to the device manufacturing process.Devices undergo 100% inspection at final assembly for the condition of the embolic coil.Thus, it is not likely that the 3mm x 6cm micrusframe 14 coil left the manufacturing facility with the embolic coil in stretched condition and with the dpu protruding from the introducer as noted during the visual and microscopic inspections.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
The healthcare professional reported that during an aneurysm coil embolization procedure, it was reported that the 3mm x 6cm micrusframe 14 coil (mfr140306 / l17147) failed to be re-sheathed.No further information related to the procedure or to the device issue is available.There was no report of any patient consequence.The complaint device was returned for evaluation.During the microscopic inspection of the returned device, the embolic coil was observed in stretched condition.Based on the product analysis on (b)(6) 2021, this event has been deemed mdr reportable as a ¿malfunction.¿.
|